Altered gene expression in a clonal epidermal cell model of carcinogenesis identified by RNA differential display

Carcinogenesis

Volumn 19, Issue 4, 1998, Pages 683-686

  Liu, Yuangang ^a   Kulesz Martin, Molly F ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; COMPLEMENTARY DNA; PROTEIN P53; RNA;

ANIMAL CELL; ARTICLE; CELL AGGREGATION; EPIDERMIS CELL; GENE EXPRESSION REGULATION; KERATINOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMA; PHENOTYPE; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; STEM CELL;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CLONE CELLS; CLONING, MOLECULAR; EPIDERMIS; GENE EXPRESSION; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; RNA; SEQUENCE HOMOLOGY, NUCLEIC ACID; SKIN NEOPLASMS;

EID: 0031867667     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.4.683     Document Type: Article

References (32)

1. Kulesz-Martin,M.F., Penetrante,R. and East,C.J. (1988) Benign and malignant tumor stages in a mouse keratinocyte line treated with 7,12-dimethylbenz[α]anthracene in vitro. Carcinogenesis, 9, 171-174.
2. Kulesz-Martin,M.F., Yoshida,M.A., Prestine,L., Yuspa,S.H. and Bertram,J.S. (1985) Mouse cell clones for improved quantitation of carcinogen-induced altered differentiation. Carcinogenesis, 6, 1245-1254.
3. Kulesz-Martin,M., Blumenson,L. and Lisafeld,B. (1986) Retinoic acid enhancement of an early step in the transformation of mouse epidermal cells in vitro. Carcinogenesis, 7, 1425-1429.
4. Schneider,B.L., Bowden,G.T., Sutter,C., Schweizer,J., Han,K.A. and Kulesz-Martin,M.F (1993) 7,12-Dimethylbenz[α]anthracene-induced mouse keratinocyte malignant transformation independent of Harvey ras activation. J. Invest. Dermatalogy, 101, 595-599.
5. Liang,P. and Pardee,A.B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-971.
6. Han,K.A. and Kulesz-Martin,M.F. (1992) Altered expression of wild-type p53 tumor suppressor gene during murine epithelial cell transformation. Cancer Res., 52, 749-753.
7. Livingstone,L.R., White,A., Sprouse,J., Livanos,E., Jacks,T. and Tlsty,T.D. (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923-935.
8. Yin,Y., Tainsky,M.A., Bischoff,F.Z., Strong,L.C. and Wahl,G.M. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70, 937-948.
9. Eyfjord,J.E., Thorlacius,S., Steinarsdottir,M., Valgardsdottir,R., Ogmundsdottir,H.M. and Anamthawat-Jonsson,K. (1995) P53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Res., 55, 646-651.
10. Callard,D., Lescure,B. and Mazzoloni,L. (1994) A method for the elimination of false positives generated by the mRNA differential display technique. BioTechniques, 16, 1096-1102.
11. Shoham,N.G., Arad,T., Rosin-Abersfeld,R., Mashiah,P., Gazit,A. and Yaniv,A. (1996) Differential display assay and analysis. BioTechniques, 20, 182-184.
12. Bellosta,P., Costa,M., Lin,D.A. and Basilico,C. (1995) The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding. Mol. Cell. Biol., 15, 614-625.
13. Janssen,J.W., Schulz,A.S., Steenvoorden,A.C., Schmidberger,M., Strehl,S., Ambros,P.F. and Bartram,C.R. (1991) A novel putative tyrosine kinase receptor with oncogenic potential. Oncogens, 6, 2113-2120.
14. O'Bryan,J.P., Frye,R.A., Cogswell,P.C., Neubauer,A., Kitch,B., Prokop,C., Espinosa,R.,III, Le Beau,M.M., Earp,H.S. and Liu,E.T. (1991) AXL, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol. Cell. Biol., 11, 5016-5031.
15. Challier,C., Uphoff,C.C., Janssen,J.W. and Drexler,H.G. (1996) Differential expression of the UFO/AXL oncogene in human leukemia-lymphoma cell lines. Leukemia, 10, 781-787.
16. Neubauer,A., Fiebeler,A., Graham,D.K., O'Bryan,J.P., Schmidt,C.A., Barckow,P., Serke,S., Siegert,W., Snodgrass,H.R., Huhn,D. et al. (1994) Expression of AXL, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood, 84, 1931-1941.
17. Craven,R.J., Xu,L.H., Weiner,T.M., Fridell,Y.W., Dent,G.A., Srivastava,S., Varnum,B., Liu,E.T. and Cance,W.G. (1995) Receptor tyrosine kinases expressed in metastatic colon cancer. Int. J. Cancer, 60, 791-797.
18. Rescigno,J., Mansukhani,A. and Basilico,C. (1991) A putative receptor tyrosine kinase with unique structural topology. Oncogene, 6, 1909-1913.
19. Varnum,B.C., Young,C., Elliott,G., Garcia,A., Bartlcy,T.D., Fridell,Y.W., Hunt,R.W., Trail,G., Clogston,C., Toso,R.J. et al. (1995) AXL receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature, 373, 623-626.
20. Manfioletti,G., Brancolini,C., Avanzi,G. and Schneider,C. (1993) The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol. Cell. Biol., 13, 4976-4985.
21. Li,R., Chen,J., Hammonds,G., Phillips,H., Armanini,M., Wood,P., Bunge,R., Godowski,P.J., Sliwkowski,M.X. and Mather,J.P. (1996) Identification of Gas6 as a growth factor for human Schwann cells. J. Neuroscience, 16, 2012-2019.
22. Goruppi,S., Ruaro,E. and Schneider,C. (1996) Gas6, the ligand of AXL tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene, 12, 471-480.
23. Fridell,Y.W., Jin,Y., Quilliam,L.A., Burchert,A., McCloskey,P., Spizz,G., Varnum,B., Der,C. and Liu,E.T. (1996) Differential activation of the Rasl extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the AXL receptor tyrosine kinase. Mol. Cell. Biol., 16, 135-145.
24. Schneider,B.L., Kulesz-Martin,M. and Bowden,G.T. (1995) Induced terminal differentiation and tumorigenic suppression in murine keratinocyte somatic-cell hybrids. Mol. Carcinogen., 13, 6-14.
25. Stoler,A.B., Stenback,F. and Balmain,A. (1993) The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. J. Cell Biology, 122, 1103-1117.
26. Fearon,E.R. and Vogelstein,B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
27. Yuspa,S.H., Dlugosz,A.A., Cheng,C.K., Denning,M.F., Tennenbaum,T., Click,A.B. and Weinberg,W.C. (1994) Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. J. Invest. Dermatology, 103, 90S-95S.
28. Pierceall,W.E., Goldberg,L.H., Tainsky,M.A., Mukhopadhyay,T. and Ananthaswamy,H.N. (1991) Ras gene mutation and amplification in human nonmelanoma skin cancers. mol. Carcinogen., 4, 196-202.
29. Lieu,F., Yamahish,K., Konishi,K., Kishimoto,S. and Yasuno,H. (1991) Low incidence of Ha-ras oncogene mutations in human epidermal tumors. Cancer Lett., 59, 231-235.
30. Kemp,C.J., Donehower,L.A., Bradley,A. and Balmain,A. (1993) Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell, 74, 813-822.
31. Greenhalgh,D.A., Wang,X.J., Donehower,L.A. and Roop,D.R. (1996) Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa. v-fos, or human transforming growth factor alpha. Canter Res., 56, 4413-4423.
32. Balmain,A., Krumlauf,R., Vass,J.K. and Birnie,G.D. (1982) Cloning and characterisation of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids Res., 10, 4259-4277.